已核实 DOI 相关产品: 0

Design, Synthesis, and Antimicrobial Activity Evaluation of 5-(3/4-Hydroxybenzylidene)thiazolidine-2,4-dione Derivatives

Journal 2026 · IF 0.8 · 95(12): 3886-3902 · 发表于 2026 年 1 月 12 日
作者: Lv Yingmei,Shi Lele,Luo Xi,Huang Yuhang,Du Zhenting
阅读全文 在 PubMed 查看

摘要

Thiazolidine-2,4-dione (TZD), a privileged scaffold, is a versatile pharmacophore and outstanding sulphur-containing heterocyclic compound found in various drugs. In this work, forty-two substituted 5-arylidene-1,3-thiazolidine-2,4-diones derivatives have been designed and synthesized by introducing sulfonyl groups, benzoyl groups, and amide groups into 5-(3/4-hydroxybenzylidene)thiazolidine-2,4-dione through Knoevenagel condensation, and their antibacterial activities were evaluated in vitro. As a result, thirty-five compounds were new compounds, and seven compounds were known compounds. The in vitro assay results disclosed that compared with B/C-series, A-series compounds presented remarkable antimicrobial activity against S. aureus, E. faecalis , and E. faecium . All twenty-one synthesized A-series compounds exhibited excellent antibacterial activity against S. aureus (MIC 80 ≤ 128 µg/mL). Among these, three compounds demonstrated the highest anti- E. faecalis activities (MIC 80 = 8 µg/mL), while E. faecium showed antibacterial susceptibility to A-series compounds except two of the investigated compounds p -cyanophenyl and p -trifluoromethoxyphenyl substituted sulfonate esters. In contrast, the B-series displayed limited activity, with only three compounds showing measurable anti- S. aureus effects, among which substituted phenyl benzoates exhibited the best antibacterial action against E. faecium (MIC 80 = 64 µg/mL). The C-series compounds demonstrated the weakest activity profile, with two N -substituted acetamides ( N -phenyl and N -methylphenyl) displaying moderate anti- S. aureus activity (MIC 80 = 128 µg/mL), which merely compound N - o -nitrophenyl was sensitive to E. faecalis (MIC 80 = 256 µg/mL). SAR analysis revealed that synthetic TZD-derivatives with substituted sulfonyl groups significantly enhanced antibacterial activity against all tested Gram-positive bacterial strains. These molecules may serve as lead compounds for developing more effective and less toxic antibacterial agents.